These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28473507)

  • 21. Assessment of patients with low-risk chest pain in the emergency department: Head-to-head comparison of exercise stress echocardiography and exercise myocardial SPECT.
    Conti A; Sammicheli L; Gallini C; Costanzo EN; Antoniucci D; Barletta G
    Am Heart J; 2005 May; 149(5):894-901. PubMed ID: 15894974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary computed tomography versus exercise testing in patients with stable chest pain: comparative effectiveness and costs.
    Genders TS; Ferket BS; Dedic A; Galema TW; Mollet NR; de Feyter PJ; Fleischmann KE; Nieman K; Hunink MG
    Int J Cardiol; 2013 Aug; 167(4):1268-75. PubMed ID: 22520158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the cost-effectiveness of stress myocardial SPECT and stress echocardiography in suspected coronary artery disease considering the prognostic value of false-negative results.
    Lee DS; Jang MJ; Cheon GJ; Chung JK; Lee MC
    J Nucl Cardiol; 2002; 9(5):515-22. PubMed ID: 12360132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative cost-effectiveness of non-invasive imaging tests in patients presenting with chronic stable chest pain with suspected coronary artery disease: a systematic review.
    van Waardhuizen CN; Khanji MY; Genders TSS; Ferket BS; Fleischmann KE; Hunink MGM; Petersen SE
    Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):245-260. PubMed ID: 29474724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic analysis including long-term risks and costs of alternative diagnostic strategies to evaluate patients with chest pain.
    Bedetti G; Pasanisi EM; Pizzi C; Turchetti G; Loré C
    Cardiovasc Ultrasound; 2008 May; 6():21. PubMed ID: 18510723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis of suspected coronary artery disease in women: a cost-effectiveness analysis.
    Kim C; Kwok YS; Saha S; Redberg RF
    Am Heart J; 1999 Jun; 137(6):1019-27. PubMed ID: 10347326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effectiveness of coronary computed tomography angiography and functional testing for the diagnosis of obstructive coronary artery disease: results from the individual patient data Collaborative Meta-Analysis of Cardiac CT (COME-CCT).
    Schlattmann P; Wieske V; Bressem KK; Götz T; Schuetz GM; Andreini D; Pontone G; Alkadhi H; Hausleiter J; Zimmermann E; Gerber B; Shabestari AA; Meijs MFL; Sato A; Øvrehus KA; Jenkins SMM; Knuuti J; Hamdan A; Halvorsen BA; Mendoza-Rodriguez V; Rixe J; Wan YL; Langer C; Leschka S; Martuscelli E; Ghostine S; Tardif JC; Sánchez AR; Haase R; Dewey M
    Insights Imaging; 2024 Aug; 15(1):208. PubMed ID: 39143443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cost-effectiveness of cardiac computed tomography for patients with stable chest pain.
    Agus AM; McKavanagh P; Lusk L; Verghis RM; Walls GM; Ball PA; Trinick TR; Harbinson MT; Donnelly PM
    Heart; 2016 Mar; 102(5):356-62. PubMed ID: 26769552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of a novel blood-pool contrast agent in the setting of chest pain evaluation in an emergency department.
    Espinosa G; Annapragada A
    AJR Am J Roentgenol; 2013 Oct; 201(4):710-9. PubMed ID: 24059359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-Effectiveness of Cardiovascular Magnetic Resonance in Diagnosing Coronary Artery Disease in the Australian Health Care System.
    Kozor R; Walker S; Parkinson B; Younger J; Hamilton-Craig C; Selvanayagam JB; Greenwood JP; Taylor AJ
    Heart Lung Circ; 2021 Mar; 30(3):380-387. PubMed ID: 32863111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of a management strategy based on exercise echocardiography versus exercise electrocardiography in patients presenting with suspected angina during long term follow up: A randomized study.
    Gurunathan S; Zacharias K; Akhtar M; Ahmed A; Mehta V; Karogiannis N; Vamvakidou A; Khattar R; Senior R
    Int J Cardiol; 2018 May; 259():1-7. PubMed ID: 29579580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronary computed tomography as a cost-effective test strategy for coronary artery disease assessment - a systematic review.
    Zeb I; Abbas N; Nasir K; Budoff MJ
    Atherosclerosis; 2014 Jun; 234(2):426-35. PubMed ID: 24769305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of substituting dual-energy CT for SPECT in the assessment of myocardial perfusion for the workup of coronary artery disease.
    Meyer M; Nance JW; Schoepf UJ; Moscariello A; Weininger M; Rowe GW; Ruzsics B; Kang DK; Chiaramida SA; Schoenberg SO; Fink C; Henzler T
    Eur J Radiol; 2012 Dec; 81(12):3719-25. PubMed ID: 21277132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of initial stress cardiovascular MR, stress SPECT or stress echocardiography as a gate-keeper test, compared with upfront invasive coronary angiography in the investigation and management of patients with stable chest pain: mid-term outcomes from the CECaT randomised controlled trial.
    Thom H; West NE; Hughes V; Dyer M; Buxton M; Sharples LD; Jackson CH; Crean AM;
    BMJ Open; 2014 Feb; 4(2):e003419. PubMed ID: 24508847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative clinical and economic impact of exercise echocardiography vs. exercise electrocardiography, as first line investigation in patients without known coronary artery disease and new stable angina: a randomized prospective study.
    Zacharias K; Ahmed A; Shah BN; Gurunathan S; Young G; Acosta D; Senior R
    Eur Heart J Cardiovasc Imaging; 2017 Feb; 18(2):195-202. PubMed ID: 27013248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrospective Comparison of Cardiac Testing and Results on Inpatients with Low Pretest Probability Compared with Moderate/High Pretest Probability for Coronary Artery Disease.
    Lear A; Huber M; Canada A; Robertson J; Bosman E; Zyzanski S
    J Am Board Fam Med; 2018; 31(2):219-225. PubMed ID: 29535238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Significance of Equivocal Exercise Treadmill ECG for Intermediate Risk Chest Pain Assessment - Insight From Coronary CT Angiography Data.
    Lau GTE; Wei H; Wickham J; To ACY
    Heart Lung Circ; 2018 Jan; 27(1):50-57. PubMed ID: 28320636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of screening of coronary artery disease in patients with type 2 DIABetes at a very high cardiovascular risk (SCADIAB study) rational and design.
    Mohammedi K; Préaubert N; Cariou T; Rigalleau V; Foussard N; Piazza L; Bairras-Martin C; Couffinhal T; Bezin J; Benard A
    Cardiovasc Diabetol; 2021 Mar; 20(1):63. PubMed ID: 33714278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between pretest probability of coronary artery disease and stress test utilization and outcomes in a chest pain observation unit.
    Napoli AM
    Acad Emerg Med; 2014 Apr; 21(4):401-7. PubMed ID: 24730402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact on service provision for non-invasive cardiac imaging following NICE recommendations: an observational study.
    Garg P; Ashrafi R; Feeney L; Lagan J; Wong P; Rodrigues E; Davis G
    Postgrad Med J; 2011 Jul; 87(1029):445-9. PubMed ID: 21406591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.